NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q4 2023 Earnings Call Transcript
Operator: Good morning everyone and welcome to the NRx Pharmaceuticals, Inc. Fourth Quarter and Full Year 2023 Results Conference Call.
Nrx Pharmaceuticals Inc. (NRXP)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Sage Rock Capital Management Atull Khanna | 0 | $0 | -100% | 0% |
| 2. | Ionic Capital Management Bart Baum | 0 | $0 | -100% | 0% |
| 3. | 0 | $0 | -100% | 0% | |
| 4. | 0 | $0 | -100% | 0% | |
| 5. | Ursa Fund Management Andrew Hahn | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.32 | 35,000 | 105,000 | 2023-08-30 | Filing | ||
| $0.29 | 70,000 | 570,000 | 2023-08-30 | Filing | ||
| $0.33 | 100,000 | Large Shareholder, Officer, Director | 446,332 | 2023-08-23 | Filing | |
| $0.32 | 200,000 | Large Shareholder, Officer, Director | 346,332 | 2023-08-22 | Filing | |
| $1.17 | 50,000 | 50,000 | 2022-12-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.00 | 400,000 | 12,899,997 | 2022-12-07 | Filing | ||
| $1.50 | 8,441 | Large Shareholder | 9,634,793 | 2022-11-30 | Filing | |
| $1.50 | 13,730 | Large Shareholder | 9,643,234 | 2022-11-29 | Filing | |
| $1.05 | 33,018 | Large Shareholder | 9,656,964 | 2022-11-17 | Filing | |
| $1.02 | 133,719 | Large Shareholder | 9,689,982 | 2022-11-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
11 Most Promising Psychedelic Stocks According to Hedge Funds
In this piece, we will take a look at the 11 most promising psychedelic stocks according to hedge funds.
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q3 2023 Earnings Call Transcript
Operator: Thank you for standing by. This is the conference operator. Welcome to NRX Pharmaceuticals' Third Quarter 2023 Earnings Conference Call.
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q2 2023 Earnings Call Transcript
Operator: Good day and welcome to the NRX Pharmaceuticals Incorporated Second Quarter 2023 Earnings Conference Call. [Operator Instructions]. I would now like to turn the conference over to Mr.
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q1 2023 Earnings Call Transcript
Operator: Good day, everyone, and welcome to NRx Pharmaceuticals’ First Quarter 2023 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions].
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q4 2022 Earnings Call Transcript
Operator: Good afternoon and welcome to the NRx Pharmaceuticals Full Year 2022 Results Conference Call. All participants will be in a listen-only mode.
Hedge Fund and Insider Trading News: Carl Icahn, Ray Dalio, Anthony Scaramucci, NRX Pharmaceuticals Inc (NRXP), Corsair Gaming, Inc. (CRSR), and More
Billionaire investor Carl Icahn began shorting GameStop Corp.
10 Unknown Biotech Stocks That Can Explode in 2022
In this article, we discuss the 10 unknown biotech stocks that can explode in 2022.
Billionaire Hedge Funds
